These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 35018703)
1. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study. Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703 [TBL] [Abstract][Full Text] [Related]
2. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685 [TBL] [Abstract][Full Text] [Related]
4. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma. Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846 [TBL] [Abstract][Full Text] [Related]
5. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis. Gupta KK; De M; Athanasiou T; Georgalas C; Garas G Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678 [TBL] [Abstract][Full Text] [Related]
6. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial. de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692 [TBL] [Abstract][Full Text] [Related]
7. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT? Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma. Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577 [TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124 [TBL] [Abstract][Full Text] [Related]
10. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315 [TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606 [TBL] [Abstract][Full Text] [Related]
12. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy. Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507 [TBL] [Abstract][Full Text] [Related]
13. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom. O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan. Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582 [TBL] [Abstract][Full Text] [Related]
15. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD; Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation. Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038 [TBL] [Abstract][Full Text] [Related]
17. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Sinclair CF; McColloch NL; Carroll WR; Rosenthal EL; Desmond RA; Magnuson JS Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1112-6. PubMed ID: 22106235 [TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. Dziegielewski PT; Teknos TN; Durmus K; Old M; Agrawal A; Kakarala K; Marcinow A; Ozer E JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1099-108. PubMed ID: 23576186 [TBL] [Abstract][Full Text] [Related]
19. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer. Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886 [TBL] [Abstract][Full Text] [Related]
20. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer. Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]